Showing results (1-10 of 555) with videos related to
Sort By:
Pageof 56
Current Opinion in Neurology and Neurosurgery|June 1, 1992
Pathogenesis of Parkinson's diseaseP Riederer, K W LangeNeuroscience and Biobehavioral Reviews|July 1, 1997
Dopamine/glutamate interactions in Parkinson's diseaseK W Lange, J Kornhuber, P RiedererAdvances in Neurology|January 1, 1993
Recent advances in pharmacological therapy of Parkinson's diseaseP Riederer, K W Lange, M B YoudimJournal of Neural Transmission. Supplementum|January 1, 1992
Neurotoxicity and neuroprotection in Parkinson's diseaseK W Lange, M B Youdim, P RiedererClinical Pharmacology and Therapeutics|December 1, 1994
Biochemical actions of l-deprenyl (selegiline)K W Lange, P Riederer, M B YoudimNeuroscience Letters|August 17, 1992
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseE Sofic, K W Lange, K Jellinger, et al.Arzneimittel-Forschung|February 1, 1992
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophreniaP Riederer, K W Lange, J Kornhuber, et al.Journal of Neural Transmission. Supplementum|January 1, 1991
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosisP Riederer, K W Lange, J Kornhuber, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolismM Naumann, M Götz, K Reiners, et al.Pageof 56